Review
Open access
Oct 2026
SGLT2 inhibitors and exercise in diabetic kidney disease: mechanistic rationale, emerging clinical evidence, and future perspectives
Diabetic kidney disease (DKD) is a major complication of diabetes and a leading cause of chronic kidney disease and kidney failure worldwide. Despite substantial advances in pharmacological therapy, residual risks of renal and cardiovascular disease remain considerable, underscoring the need for complementary therapeut...
Hua-Juan Li, Ming-Xian Ai, Xiang-Yu He et al.
· Frontiers in Medicine · 0 citations